Ceribell │ AI-Powered Point-of-Care EEG · 3 days ago
Director/Senior Director, Strategy & Business Development
Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. They are seeking a highly analytical and experienced Director/Senior Director of Strategy and Business Development to define and drive key strategic initiatives, optimize internal operational effectiveness, and lead the company's growth through strategic partnerships.
BiotechnologyHealth CareHealth DiagnosticsMedical Device
Responsibilities
Develop, champion, and execute the strategy for partnering with pharmaceutical companies, aligning with Ceribell’s long-term business growth opportunities
Identify, evaluate, and prioritize potential partners for collaborations focused on companion diagnostics, and using EEG data, or co-commercialization agreements in the neurological space
Lead relationship building, conduct due diligence, and support negotiation of complex strategic alliance and license agreements
Conduct robust financial modeling and market sizing analysis to support strategic decision-making
Develop clear, high-impact presentations and communication materials for internal stakeholders and external partners, translating complex technical and business risks into clear executive recommendations
Collaborate synergistically with the CEO to lead and manage strategic projects, developing detailed work plans, conducting market analysis, and preparing final recommendations for the executive leadership team (ELT) and the Board of Directors
Coordinate multifaceted projects that demand cross-functional cooperation, guaranteeing punctual completion and alignment with overarching objectives
Support the ongoing business strategy by providing data-driven analysis on market access, competitive landscape, and pricing strategy for the Ceribell EEG System
Facilitate and organize critical day-to-day operations of the CEO’s office, including planning and structuring CEO staff meetings, tracking key decisions, and ensuring timely execution of executive priorities
Qualification
Required
Advanced degree (Ph.D. or Master's) in a STEM field (Science, Technology, Engineering, or Mathematics) is strongly preferred
3+ years experience with management consulting, investment banking, or similar roles
Demonstrated track record in a senior management capacity, preferably within the medical device or healthcare sector
Proficiency in strategic analysis and cogent problem-solving
Exemplary communication and interpersonal aptitude, facilitating collaboration at all echelons of the organization
Proven ability to lead complex projects and drive results within a fast-paced, high-growth MedTech environment
Preferred
Business development experience at pharmaceutical companies is preferred
Neuroscience, Biomedical Engineering, or related fields are highly valued
Benefits
Performance-based incentive compensation (varies by role)
Equity opportunities
100% Employer paid Health Benefits for Employees
50% - 70% Employer paid Health, Dental & Vision for dependents (depending on plan selection)
100% paid Life and Long-Term Disability Insurance
401(k) with a generous company match
Employee Stock Purchase Plan (ESPP) with a discount
Monthly cell phone stipend
Flexible paid time off
13 Paid Holidays + 3 Company Wellness Days
Excellent parental leave policy
Fantastic culture with tremendous career advancement opportunities
Joining a mission-minded organization!
Company
Ceribell │ AI-Powered Point-of-Care EEG
Ceribell is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions.
H1B Sponsorship
Ceribell │ AI-Powered Point-of-Care EEG has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (4)
2022 (5)
2020 (1)
Funding
Current Stage
Public CompanyTotal Funding
$171MKey Investors
Ally Bridge GroupHorizon Technology Finance
2024-10-11IPO
2022-09-21Series C· $50M
2021-04-29Series C· $53M
Recent News
GlobeNewswire
2026-01-16
2026-01-08
Company data provided by crunchbase